Japan's Ono Pharma inks $700 M ADC deal with Korean firm LigaChem Biosciences

Japan-based Ono Pharmaceutical Co. has entered into a license agreement with LigaChem Biosciences, Inc., in South Korea,...

October 14, 2024 | Monday | News
Japanese startup Alpha Fusion accelerates astatine-based drug discovery with Series B funding

Alpha Fusion, Inc., working on research outcomes from Osaka University and the Japan Science and Technolo...

October 13, 2024 | Sunday | News
World Companion Diagnostics and Liquid Biopsy Summit APAC to Unite 100+ Precision Medicine Experts

This exciting forum will gather the field to discuss the latest advancements in NGS, biomarker development, clinical tri...

October 10, 2024 | Thursday | News
Eli Lilly invests $4.5 B to create Lilly Medicine Foundry for drug development

American pharmaceutical firm Eli Lilly and Company has announced a $4.5 billion investment to create the Lilly...

October 4, 2024 | Friday | News
BIOCHINA 2025: China’s Largest Bio Convention to Host Over 3,000 Biotech Companies

Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition o...

September 12, 2024 | Thursday | News
Bridge Biotherapeutics & HitGen initiate research collaboration to advance novel cancer therapeutics programme

Bridge Biotherapeutics, a startup based in the Republic of Korea and the US, has entered into a joint research agreement...

August 24, 2024 | Saturday | News
Innovations in Pharmaceutical Drug Delivery Systems

Advancements in Drug Delivery Technologies Innovative drug delivery systems have emerged to address the limitations of ...

July 13, 2024 | Saturday | News
Australia invests $2 M to establish Queensland Drug Discovery Alliance

A $2 million grant awarded to establish the Queensland Drug Discovery Alliance (QDDA) will align and grow Queensland&rsq...

August 1, 2024 | Thursday | News
AstraZeneca partners with Japanese startup United Immunity for drug delivery tech research

AstraZeneca K.K. and United Immunity have signed an agreement for joint research on next-generation lipid nanoparticles ...

July 30, 2024 | Tuesday | News
Scientists in Australia invent new AI tool for rapid and cost-effective drug discovery

Australian researchers, led by Monash University, have invented a new artificial intelligence (AI) tool which is poised ...

June 19, 2024 | Wednesday | News
AbbVie inks deal worth $1.56 B with China's FutureGen to develop IBD therapy

US-based firm AbbVie and FutureGen Biopharmaceutical (Beijing) have announced a license agreement to develop FG-M701, a ...

June 17, 2024 | Monday | News
Oncocross expands collaboration with JW Pharma for AI-based oncology drug discovery in Korea

Oncocross, a Seoul-based artificial intelligence (AI) drug discovery and development biotech startup, has signed a joint...

May 27, 2024 | Monday | News
Japan's Shionogi announces $150 M deal to develop first oral therapy for Pompe Disease

Japan-based Shionogi & Co. and Maze Therapeutics, Inc., in the US, have completed an exclusive worldwide license agr...

May 13, 2024 | Monday | News
Singapore scientists develop high-precision tissue analysis AI tool to support drug discovery, diagnosis

A team of scientists from A*STAR’s Genome Institute of Singapore (GIS) and Bioinformatics Institute (BII) has deve...

May 8, 2024 | Wednesday | News
invoX Pharma and Insilico Medicine partner to enhance R&D using AI

invoX Pharma, a UK-based research-driven global biopharmaceutical company with an advancing pipeline of innovative produ...

April 24, 2024 | Wednesday | News
Japanese Foundation for Cancer Research collaborates with Takeda Pharma

Japanese Foundation for Cancer Research (JFCR) and Takeda Pharmaceutical have signed a partnership agreement with the go...

April 24, 2024 | Wednesday | News
Takeda, Astellas and Sumitomo to establish JV for drug discovery programmes in Japan

Takeda Pharmaceutical, Astellas Pharma and Sumitomo Mitsui Banking Corporation (SMBC), in Japan, have signed a master ag...

April 23, 2024 | Tuesday | News
Japan's Sosei Heptares inks €750 M deal with Boehringer Ingelheim for schizophrenia treatment

German firm Boehringer Ingelheim and Japan-based Sosei Group Corporation have entered a global collaboration and exclusi...

March 12, 2024 | Tuesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls